These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10391787)

  • 1. No winners in patent shootout.
    Barinaga M
    Science; 1999 Jun; 284(5421):1752-3. PubMed ID: 10391787
    [No Abstract]   [Full Text] [Related]  

  • 2. UC-Genentech trial.
    Seeburg PH
    Science; 1999 May; 284(5419):1465-6. PubMed ID: 10383323
    [No Abstract]   [Full Text] [Related]  

  • 3. Charges fly in $1bn hormone patent battle.
    Dalton R
    Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
    [No Abstract]   [Full Text] [Related]  

  • 4. Startling revelations in UC-Genentech battle.
    Marshall E
    Science; 1999 May; 284(5416):883, 885-6. PubMed ID: 10357665
    [No Abstract]   [Full Text] [Related]  

  • 5. US jury split over hormone patent case..
    Dalton R
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376586
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech patents. Genentech, UC settle suit for $200 million.
    Barinaga M
    Science; 1999 Nov; 286(5445):1655. PubMed ID: 10610555
    [No Abstract]   [Full Text] [Related]  

  • 7. UC-Genentech trial.
    Henner D; Goeddel DV; Heyneker H; Itakura K; Tansura D
    Science; 1999 May; 284(5419):1465. PubMed ID: 10383322
    [No Abstract]   [Full Text] [Related]  

  • 8. Genentech pays $200m over growth hormone 'theft'.
    Dalton R; Schiermeier Q
    Nature; 1999 Nov; 402(6760):335. PubMed ID: 10586857
    [No Abstract]   [Full Text] [Related]  

  • 9. Statement from Peter Seeburg.
    Seeburg PH
    Nature; 1999 May; 399(6734):298. PubMed ID: 10360565
    [No Abstract]   [Full Text] [Related]  

  • 10. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 11. Intellectual property. Depth charges aimed at Columbia's 'submarine patent'.
    Marshall E
    Science; 2003 Jul; 301(5632):448. PubMed ID: 12881539
    [No Abstract]   [Full Text] [Related]  

  • 12. as Seeburg faces misconduct inquiry.
    Abbott A
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376587
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 14. Scientific misconduct. Researcher rebuked for 20-year-old misdeed.
    Hagmann M
    Science; 1999 Dec; 286(5448):2249-50. PubMed ID: 10636777
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV/AIDS. Tangled patent dispute over 'free' drug-resistance database.
    Cohen J
    Science; 2009 Feb; 323(5918):1156-7. PubMed ID: 19251598
    [No Abstract]   [Full Text] [Related]  

  • 16. Theory of knowledge and biotech patents: worlds apart?
    Altamirano-Bustamante MM; de Hoyos A; Olivé L
    Nat Biotechnol; 2011 Nov; 29(11):977-8. PubMed ID: 22068530
    [No Abstract]   [Full Text] [Related]  

  • 17. Intellectual property. NIH roils academe with advice on licensing DNA patents.
    Malakoff D
    Science; 2004 Mar; 303(5665):1757-8. PubMed ID: 15031474
    [No Abstract]   [Full Text] [Related]  

  • 18. Patents. Signature on visitor's form fuels Stanford v. Roche court battle.
    Marshall E
    Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR, surrogate licensing, and scientific discovery.
    Contreras JL; Sherkow JS
    Science; 2017 Feb; 355(6326):698-700. PubMed ID: 28209863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.